AL Capital Holdings 2016 Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
CPHO-M
IL0010843675
Pharmaceuticals
Sales 2022 | 49.3 18.81K | Sales 2023 | 44.23 16.87K | Capitalization | 25.49M 9.72B |
---|---|---|---|---|---|
Net income 2022 | -48M -18.31B | Net income 2023 | -88M -33.57B | EV / Sales 2022 | 1,234,605 x |
Net Debt 2022 | 17.5M 6.68B | Net Debt 2023 | 13.42M 5.12B | EV / Sales 2023 | 879,698 x |
P/E ratio 2022 |
-0.97
x | P/E ratio 2023 |
-0.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.73% |
Managers | Title | Age | Since |
---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Revital Aviram
BRD | Director/Board Member | 66 | 15-02-14 |
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
1st Jan change | Capi. | |
---|---|---|
+17.79% | 3.5B | |
+101.46% | 1.92B | |
+84.13% | 61.64M |